当前位置:首页 - 行情中心 - 诚意药业(603811) - 财务分析 - 利润表

诚意药业

(603811)

  

流通市值:25.56亿  总市值:25.56亿
流通股本:3.27亿   总股本:3.27亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入459,487,529.22320,859,909.37147,830,388.05654,972,841.26
营业收入459,487,529.22320,859,909.37147,830,388.05654,972,841.26
二、营业总成本393,013,923.73267,812,880.25122,646,292.57534,085,912.33
营业成本166,641,657.07115,622,465.4352,009,448.21206,814,979.49
税金及附加7,136,617.594,377,445.641,464,973.397,766,940.69
销售费用108,057,755.271,618,235.2634,273,172.44180,693,309.65
管理费用70,560,205.8249,122,348.2724,517,349.491,108,968.34
研发费用35,398,105.3423,061,605.158,275,164.8944,304,378.52
财务费用5,219,582.714,010,780.52,106,184.243,397,335.64
其中:利息费用11,523,084.47,556,946.23,474,097.999,132,706.24
其中:利息收入6,424,310.273,548,392.231,588,119.812,398,073.87
加:公允价值变动收益----3,547,000
加:投资收益49,871,213.3939,580,643.3816,954,376.4246,680,996.08
资产处置收益-354.08-354.08-57,939.65
资产减值损失(新)-2,612,500.92-1,824,909.74-1,673,438.69-11,207,874.11
信用减值损失(新)553,761.55161,216.08383,374.32-150,372.68
其他收益4,550,963.482,803,235.12947,760.211,708,227.78
营业利润平衡项目0000
四、营业利润118,836,688.9193,766,859.8841,796,167.73164,428,845.65
加:营业外收入610,802.58547,102.58501,901.75542,388.37
减:营业外支出390,134.34361,489.42335,666.631,130,317.65
利润总额平衡项目0000
五、利润总额119,057,357.1593,952,473.0441,962,402.85163,840,916.37
减:所得税费用5,552,462.373,643,111.792,340,068.072,659,072.41
六、净利润113,504,894.7890,309,361.2539,622,334.78161,181,843.96
持续经营净利润113,504,894.7890,309,361.2539,622,334.78161,181,843.96
归属于母公司股东的净利润113,947,162.0290,599,041.7839,749,555.71161,583,203.31
少数股东损益-442,267.24-289,680.53-127,220.93-401,359.35
(一)基本每股收益0.350.280.170.69
(二)稀释每股收益0.350.280.170.69
八、其他综合收益-20,293.25-37,073.861,591.37,596.62
归属于母公司股东的其他综合收益-18,263.93-33,366.471,432.176,836.95
九、综合收益总额113,484,601.5390,272,287.3939,623,926.08161,189,440.58
归属于母公司股东的综合收益总额113,928,898.0990,565,675.3139,750,987.88161,590,040.26
归属于少数股东的综合收益总额-444,296.56-293,387.92-127,061.8-400,599.68
公告日期2023-10-272023-08-242023-04-262023-04-26
审计意见(境内)标准无保留意见
TOP↑